Literature DB >> 28531397

Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.

Marcela T Watanabe1, Raphael M Araujo1, Barbara P Vogt1, Pasqual Barretti1, Jacqueline C T Caramori2.   

Abstract

BACKGROUND AND AIMS: Hyperphosphatemia is common in patients with chronic kidney disease (CKD) stages IV and V because of decreased phosphorus excretion. Phosphatemia is closely related to dietary intake. Thus, a better understanding of sources of dietary phosphate consumption, absorption and restriction, particularly inorganic phosphate found in food additives, is key to prevent consequences of this complication. Our aims were to investigate the most commonly consumed processed foods by patients with CKD on hemodialysis, to analyze phosphate and protein content of these foods using chemical analysis and to compare these processed foods with fresh foods.
METHODS: We performed a cross-sectional descriptive analytical study using food frequency questionnaires to rank the most consumed industrialized foods and beverages. Total phosphate content was determined by metavanadate colorimetry, and nitrogen content was determined by the Kjeldahl method. Protein amounts were estimated from nitrogen content. The phosphate-to-protein ratio (mg/g) was then calculated. Processed meat protein and phosphate content were compared with the nutritional composition of fresh foods using the Brazilian Food Composition Table. Phosphate measurement results were compared with data from the Food Composition Table - Support for Nutritional Decisions. An α level of 5% was considered significant.
RESULTS: Food frequency questionnaires were performed on 100 patients (mean age, 59 ± 14 years; 57% male). Phosphate additives were mentioned on 70% of the product labels analyzed. Proteins with phosphate-containing additives provided approximately twice as much phosphate per gram of protein compared with that of fresh foods (p < 0.0001).
CONCLUSIONS: Protein and phosphate content of processed foods are higher than those of fresh foods, as well as phosphate-to-protein ratio. A better understanding of phosphate content in foods, particularly processed foods, may contribute to better control of phosphatemia in patients with CKD.
Copyright © 2016 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Food; Food additives; Hemodialysis; Nutrition; Phosphate

Mesh:

Substances:

Year:  2016        PMID: 28531397     DOI: 10.1016/j.clnesp.2016.05.001

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  6 in total

Review 1.  The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.

Authors:  Jiameng Li; Liya Wang; Mei Han; Yuqin Xiong; Ruoxi Liao; Yupei Li; Si Sun; Anil Maharjan; Baihai Su
Journal:  Nutr Diabetes       Date:  2019-04-03       Impact factor: 5.097

2.  Control of hyperphosphatemia and maintenance of calcemia in CKD.

Authors:  Aluizio Barbosa Carvalho; Fabiana Baggio Nerbass; Lilian Cuppari
Journal:  J Bras Nefrol       Date:  2021-12-03

Review 3.  Obesity, Diabetes Mellitus, and Vascular Impediment as Consequences of Excess Processed Food Consumption.

Authors:  Susmita Sinha; Mainul Haque
Journal:  Cureus       Date:  2022-09-04

Review 4.  The Importance of Phosphate Control in Chronic Kidney Disease.

Authors:  Ken Tsuchiya; Taro Akihisa
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

5.  Effects of Jerusalem Artichoke Powder and Sodium Carbonate as Phosphate Replacers on the Quality Characteristics of Emulsified Chicken Meatballs.

Authors:  Burcu Öztürk; Meltem Serdaroğlu
Journal:  Korean J Food Sci Anim Resour       Date:  2018-02-28       Impact factor: 2.622

6.  Phosphates in medications: Impact on dialysis patients
.

Authors:  Dixie-Ann Sawin; Lin Ma; Amanda Stennett; Norma Ofsthun; Rainer Himmele; Robert J Kossmann; Franklin W Maddux
Journal:  Clin Nephrol       Date:  2020-04       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.